Bausch Health Companies Inc. (BHC)
Bausch Health Companies Inc. (BHC) from its SEC filings: 2025 revenue $10.3 billion (+7% vs the year before), net margin 2%, free cash flow $1.0 billion. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Pharmaceutical Preparations |
| Revenue (2025) | $10.3 billion |
| Revenue growth | +7% |
| Net income | $157.0 million |
| Net margin | 1.5% |
| Free cash flow | $1.0 billion |
| Diluted EPS | $0.42 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +13% |
| Cash | $1.8 billion |
| Long-term debt | $19.9 billion |
| Share count, 1 year | +1% |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.